These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9669489)

  • 1. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.
    Butour JL; Moisand C; Mollereau C; Meunier JC
    Eur J Pharmacol; 1998 May; 349(1):R5-6. PubMed ID: 9669489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
    Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
    J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
    Xu IS; Wiesenfeld-Hallin Z; Xu XJ
    Neurosci Lett; 1998 Jun; 249(2-3):127-30. PubMed ID: 9682833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells.
    Olianas MC; Maullu C; Ingianni A; Onali P
    Neuroreport; 1999 Apr; 10(5):1127-31. PubMed ID: 10321496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
    Mason SL; Ho M; Nicholson J; McKnight AT
    Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y; Caló G; Guerrini R; Smith G; Lambert DG
    Neurosci Lett; 2000 Jan; 278(1-2):109-12. PubMed ID: 10643813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord.
    Carpenter KJ; Dickenson AH
    Br J Pharmacol; 1998 Nov; 125(5):949-51. PubMed ID: 9846631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.
    Yakimova KS; Pierau FK
    Neurosci Lett; 1999 Oct; 274(2):87-90. PubMed ID: 10553944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC
    Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new selective antagonist of the nociceptin receptor.
    Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
    Br J Pharmacol; 1998 Jan; 123(2):163-5. PubMed ID: 9489602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
    Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
    Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
    Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat.
    Candeletti S; Guerrini R; Calò G; Romualdi P; Ferri S
    Life Sci; 2000; 66(3):257-64. PubMed ID: 10666001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
    Schlicker E; Werthwein S; Kathmann M; Bauer U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
    Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.